← Evidence map

TrialBritish journal of cancer1995

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.

R A Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

this papercites it

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients. | OpenQuestion